可視化

クラスタサイズ(論文数)

15

クラスタの分野

2700:Medicine
(比率: 100 %)

発行年ごと論文数

著者正規化top50

著者正規化top50の共著関係

タイトル語top50

タイトル語top50の共起

ジャーナル一覧

ジャーナル分野比率


論文リスト

DOI タイトル 著者 ジャーナル 発行年 科研費成果論文
10.1007/s40121-018-0214-1 Effect And Safety Of Meropenem<U+2013>Vaborbactam Versus Best-Available Therapy In Patients With Carbapenem-Resistant Enterobacteriaceae Infections: The Tango Ii Randomized Clinical Trial Wunderink, Richard G.; Giamarellos-Bourboulis, Evangelos J.; Rahav, Galia; Mathers, Amy J.; Bassetti, Matteo; Vazquez, Jose; Cornely, Oliver A.; Solomkin, Joseph; Bhowmick, Tanaya; Bishara, Jihad; Daikos, George L.; Felton, Tim; Furst, Maria Jose Lopez; Kwak, Eun Jeong; Menichetti, Francesco; Oren, Ilana; Alexander, Elizabeth L.; Griffith, David; Lomovskaya, Olga; Loutit, Jeffery; Zhang, Shu; Dudley, Michael N.; Kaye, Keith S. Infectious Diseases And Therapy 2018 NA
10.1007/s40265-019-1055-2 Cefiderocol: A Siderophore Cephalosporin With Activity Against Carbapenem-Resistant And Multidrug-Resistant Gram-Negative Bacilli Zhanel, George G.; Golden, Alyssa R.; Zelenitsky, Sheryl; Wiebe, Karyn; Lawrence, Courtney K.; Adam, Heather J.; Idowu, Temilolu; Domalaon, Ronald; Schweizer, Frank; Zhanel, Michael A.; Lagace-Wiens, Philippe R. S.; Walkty, Andrew J.; Noreddin, Ayman; Lynch Iii, Joseph P.; Karlowsky, James A. Drugs 2019 NA
10.1016/j.ijantimicag.2018.10.007 Kazmierczak, Krystyna M.; Tsuji, Masakatsu; Wise, Mark G.; Hackel, Meredith; Yamano, Yoshinori; Echols, Roger; Sahm, Daniel F. International Journal Of Antimicrobial Agents 2019 NA
10.1016/j.ijantimicag.2018.11.001 Ceftolozane/Tazobactam For The Treatment Of Serious Pseudomonas Aeruginosa Infections: A Multicentre Nationwide Clinical Experience Bassetti, Matteo; Castaldo, Nadia; Cattelan, Annamaria; Mussini, Cristina; Righi, Elda; Tascini, Carlo; Menichetti, Francesco; Mastroianni, Claudio Maria; Tumbarello, Mario; Grossi, Paolo; Artioli, Stefania; Carannante, Novella; Cipriani, Ludovica; Coletto, Davide; Russo, Alessandro; Digaetano, Margherita; Losito, Angela Raffaella; Peghin, Maddalena; Capone, Alessandro; Nicole, Stefano; Vena, Antonio; Bassetti, Matteo; Vena, Antonio; Castaldo, Nadia; Pecori, Davide; Righi, Elda; Carnellutti, Alessia; Givone, Filippo; Graziano, Elena; Merelli, Maria; Cadeo, Barbara; Peghin, Maddalena; Cattelan, Annamaria; Cipriani, Ludovica; Coletto, Davide; Mussini, Cristina; Digaetano, Margherita; Tascini, Carlo; Carannante, Novella; Menichetti, Francesco; Verdenelli, Stefano; Fabiani, Silvia; Mastroianni, Claudio Maria; Gianluca, Russo; Oliva, Alessandra; Ciardi, Maria Rosa; Ajassa, Camilla; Tieghi, Tiziana; Tumbarello, Mario; Losito, Angela Raffaella; Raffaelli, Francesca; Grossi, Paolo; Rovelli, Cristina; Artioli, Stefania; Caruana, Giorgia; Luzzati, Roberto; Bontempo, Giulia; Petrosillo, Nicola; Capone, Alessandro; Rizzardini, Giuliano; Coen, Massimo; Passerini, Matteo; Mastroianni, Antonio; Urso, Filippo; Bianco, Maria Francesca; Borgia, Guglielmo; Gentile, Ivan; Maraolo, Alberto Enrico; Crapis, Massimo; Venturini, Sergio; Parruti, Giustino; Trave, Francesca; Angarano, Gioacchino; Carbonara, Sergio; Mariani, Michele Fabiano; Girardis, Massimo; Cascio, Antonio; Gioe, Claudia; Anselmo, Marco; Malfatto, Emanuele International Journal Of Antimicrobial Agents 2019 NA
10.1016/j.ijantimicag.2018.11.007 In Vitro Activity Of Cefiderocol, A Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated By Clinical Laboratories In North America And Europe In 2015-2016: Sidero-Wt-2015 Karlowsky, James A.; Hackel, Meredith A.; Tsuji, Masakatsu; Yamano, Yoshinori; Echols, Roger; Sahm, Daniel F. International Journal Of Antimicrobial Agents 2019 NA
10.1016/s1473-3099(18)30554-1 Cefiderocol Versus Imipenem-Cilastatin For The Treatment Of Complicated Urinary Tract Infections Caused By Gram-Negative Uropathogens: A Phase 2, Randomised, Double-Blind, Non-Inferiority Trial Portsmouth, Simon; Van Veenhuyzen, David; Echols, Roger; Machida, Mitsuaki; Ferreira, Juan Camilo Arjona; Ariyasu, Mari; Tenke, Peter; Nagata, Tsutae Den The Lancet Infectious Diseases 2018 NA
10.1016/s1473-3099(19)30403-7 Ceftolozane<U+2013>Tazobactam Versus Meropenem For Treatment Of Nosocomial Pneumonia (Aspect-Np): A Randomised, Controlled, Double-Blind, Phase 3, Non-Inferiority Trial Kollef, Marin H; Nova<U+010D>ek, Martin; Kivistik, Ulo; Rea-Neto, Alvaro; Shime, Nobuaki; Martin-Loeches, Ignacio; Timsit, Jean-Francois; Wunderink, Richard G; Bruno, Christopher J; Huntington, Jennifer A; Lin, Gina; Yu, Brian; Butterton, Joan R; Rhee, Elizabeth G The Lancet Infectious Diseases 2019 NA
10.1016/s1473-3099(20)30731-3 Cefiderocol Versus High-Dose, Extended-Infusion Meropenem For The Treatment Of Gram-Negative Nosocomial Pneumonia (Apeks-Np): A Randomised, Double-Blind, Phase 3, Non-Inferiority Trial Wunderink, Richard G; Matsunaga, Yuko; Ariyasu, Mari; Clevenbergh, Philippe; Echols, Roger; Kaye, Keith S; Kollef, Marin; Menon, Anju; Pogue, Jason M; Shorr, Andrew F; Timsit, Jean-Francois; Zeitlinger, Markus; Nagata, Tsutae D The Lancet Infectious Diseases 2021 NA
10.1016/s1473-3099(20)30796-9 Efficacy And Safety Of Cefiderocol Or Best Available Therapy For The Treatment Of Serious Infections Caused By Carbapenem-Resistant Gram-Negative Bacteria (Credible-Cr): A Randomised, Open-Label, Multicentre, Pathogen-Focused, Descriptive, Phase 3 Trial Bassetti, Matteo; Echols, Roger; Matsunaga, Yuko; Ariyasu, Mari; Doi, Yohei; Ferrer, Ricard; Lodise, Thomas P; Naas, Thierry; Niki, Yoshihito; Paterson, David L; Portsmouth, Simon; Torre-Cisneros, Julian; Toyoizumi, Kiichiro; Wunderink, Richard G; Nagata, Tsutae D The Lancet Infectious Diseases 2021 NA
10.1056/nejmc1807634 Plazomicin For Infections Caused By Carbapenem-Resistant Enterobacteriaceae Mckinnell, James A.; Dwyer, Jamie P.; Talbot, George H.; Connolly, Lynn E.; Friedland, Ian; Smith, Alex; Jubb, Adrian M.; Serio, Alisa W.; Krause, Kevin M.; Daikos, George L. New England Journal Of Medicine 2019 NA
10.1056/nejmoa1801467 Once-Daily Plazomicin For Complicated Urinary Tract Infections Wagenlehner, Florian M.E.; Cloutier, Daniel J.; Komirenko, Allison S.; Cebrik, Deborah S.; Krause, Kevin M.; Keepers, Tiffany R.; Connolly, Lynn E.; Miller, Loren G.; Friedland, Ian; Dwyer, Jamie P. New England Journal Of Medicine 2019 NA
10.1093/cid/ciy1029 Ignite4: Results Of A Phase 3, Randomized, Multicenter, Prospective Trial Of Eravacycline Vs Meropenem In The Treatment Of Complicated Intraabdominal Infections Solomkin, Joseph S; Gardovskis, Janis; Lawrence, Kenneth; Montravers, Philippe; Sway, Angie; Evans, David; Tsai, Larry Clinical Infectious Diseases 2018 NA
10.1093/cid/ciz530 Restore-Imi 1: A Multicenter, Randomized, Double-Blind Trial Comparing Efficacy And Safety Of Imipenem/Relebactam Vs Colistin Plus Imipenem In Patients With Imipenem-Nonsusceptible Bacterial Infections Motsch, Johann; Murta De Oliveira, Claudia; Stus, Viktor; Koksal, Iftihar; Lyulko, Olexiy; Boucher, Helen W; Kaye, Keith S; File, Thomas M; Brown, Michelle L; Khan, Ireen; Du, Jiejun; Joeng, Hee-Koung; Tipping, Robert W; Aggrey, Angela; Young, Katherine; Kartsonis, Nicholas A; Butterton, Joan R; Paschke, Amanda Clinical Infectious Diseases 2019 NA
10.1093/cid/ciz825 The Role Of Iron And Siderophores In Infection, And The Development Of Siderophore Antibiotics Page, Malcom G P, 0000-0002-0276-8174 Clinical Infectious Diseases 2019 NA
10.1093/cid/ciz826 Cefiderocol: Discovery, Chemistry, And In Vivo Profiles Of A Novel Siderophore Cephalosporin Sato, Takafumi; Yamawaki, Kenji Clinical Infectious Diseases 2019 NA